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In an RT–PCR study of HERV-H spliced subgenomic transcripts, we found transcripts with HERV-H leader and protease-
encoding sequences spliced to HERV-E integrase-encoding sequences in lymphocytes from healthy blood donors. In other
cell types, including two T-cell leukemia cell lines, these transcripts were absent. The PCR fragments of the hybrid transcripts
contained two open reading frames (ORFs). One was a hybrid HERV-H protease/HERV-E integrase ORF and the other was
the HERV-E envelope surface glycoprotein ORF. Alternative splice products were also identified. The genomic DNA origin of
the hybrid transcripts was shown to be a HERV-H element with a large 39-end deletion, adjacent to a HERV-E element lacking
the 59-LTR. This hybrid structure was shown to be amplified and dispersed to six different human chromosomes. Thus, a
relatively large part of full-length HERV-E elements (15–20%) is potentially under the transcriptional control of HERV-H LTRs.
The HERV-H/HERV-E junction was present in multiple copies also in the chimpanzee and gorilla, but not in the orangutan or
old world monkeys. © 1998 Academic Press
INTRODUCTION
The human genome contains large numbers of en-
dogenous retrovirus-like elements (HERVs), which
probably are remnants of past infections by exoge-
nous retroviruses of the germ-line or subsequent
bursts of retrotransposition of sometimes defective
HERVs (reviewed by Wilkinson et al., 1994). Docu-
mented biological properties of these proviruses are
the production of retroviral proteins (Kitamura et al.,
1994; Venables et al., 1995; Lo¨wer et al., 1995; Sauter
et al., 1995) and regulatory functions on adjacent cel-
lular genes, including promoter activity (Kato et al.,
1990; Feuchter et al., 1992; Mayer et al., 1993; Di
Cristofano et al., 1995; Schulte et al., 1996), tissue-
specific enhancer activity (Ting et al., 1992), and poly-
adenylation of transcripts (Goodchild et al., 1992; Kaz-
mierczak et al., 1996).
HERV-H is one of the most abundant endogenous
retroviral families in the human genome, consisting of
full-length elements (ca. 100 copies), elements deleted in
pol and env (800–900 copies), and solitary LTRs (ca. 1000
copies) (Mager and Freeman, 1987; Hirose et al., 1993).
This family entered the genome 30–40 million years ago
and has been subjected to amplifications on several
occasions in the evolution of primates (Mager and Free-
man, 1995). HERV-H elements are transcriptionally active
in, e.g., placenta and certain cancer cell lines (Johansen
et al., 1989; Wilkinson et al., 1990). The presence of large
numbers of HERV-H elements on all human chromo-
somes (Fraser et al., 1988) makes interactions with ad-
jacent cellular genes likely to be relatively common.
One way of LTR promotion of a cellular gene involves
the splicing of transcripts to downstream cellular exons.
This has been seen in HERV-H transcripts where the
leader region is joined to a phospholipase A2-related
gene (Feuchter-Murthy et al., 1993) and to the calbindin
gene (Liu and Abraham, 1991). The splice acceptor (SA)
site for env transcripts is deleted in the majority of
HERV-H elements (Lindeskog and Blomberg, 1997) and
this probably makes them more prone to splicing to
downstream cellular SAs. The splicing pattern of HERV-H
transcripts is complicated by alternative splice sites in
the protease-encoding region and near the 39-LTR
(Wilkinson et al., 1990; Lindeskog and Blomberg, 1997).
The HERV-E family consists of 35–50 full-length ele-
ments dispersed to 12 chromosomes (Steele et al., 1984;
Taruscio and Manuelidis, 1991). Some of these elements
have been dispersed to different chromosomes by am-
plification involving also flanking sequences (Steele et
al., 1986). HERV-E envelope proteins have been detected
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in placenta (Kitamura et al., 1994), where they may be
involved in normal cell function (Rabson et al., 1983).
In an RT–PCR study of HERV-H-spliced transcripts,
HERV-H/HERV-E hybrid transcripts were unexpectedly
amplified from normal lymphocyte RNA (Lindeskog and
Blomberg, 1997). In this study, we characterize these
transcripts and show that the genomic origin of the
hybrid transcripts is a structure containing adjacent
HERV-H and HERV-E elements which were joined and
amplified in the hominoid lineage after the divergence of
the orangutan.
RESULTS
Amplification of spliced HERV-H/HERV-E hybrid
transcripts from normal lymphocytes
In an RT–PCR study of HERV-H spliced transcripts in
various human cell types, we used a PCR primer pair
(PBHIS/RHENR1) from the histidine tRNA primer binding
site and a conserved sequence in the integrase-encod-
ing part of pol, situated just downstream from SA sites
used in env transcripts of many retroviruses (Lindeskog
and Blomberg, 1997).
One of several amplification products was a 414-bp
fragment, obtained from normal blood donor lymphocyte
RNA (Fig. 1). This fragment from one blood donor
(PBMC5) was cloned into a plasmid vector and five
clones were sequenced, differing by no more than two
bases from a consensus sequence, represented by
clone c7.9 (within the error frequencies expected from
reverse transcription and PCR). The clones contained
HERV-H leader and protease sequences bordered by
previously described splice sites (Wilkinson et al., 1990;
Lindeskog and Blomberg, 1997). The protease exon was
joined to a HERV-E integrase region at a SA site display-
ing a perfect match to the consensus SA sequence
(Shapiro and Senepathy, 1987), located 90 nucleotides
downstream of the previously reported putative env SA
site in the HERV-E clone 4-1 (Repaske et al., 1985) (Fig.
2). Neither of the two splice junctions were present in
genomic DNA as evidenced by PCR on lymphocyte
genomic DNA with primers from the HERV-H protease
exon (C7PRL1 and C7PRR) in combinations with PBHIS
and RHENR1 (not shown). The bands visible in Fig. 1A at
250 and 350 bp are amplification products of normal
spliced HERV-H env transcripts and have been de-
scribed before (Lindeskog and Blomberg, 1997).
Spliced HERV-H/HERV-E hybrid transcripts are
normally present in lymphocytes
The primer pair PBHIS/RHENR1 amplified visible
414-bp fragments from RNA from blood donor lympho-
cytes but not from the T-cell leukemia cell lines H9 and
MOLT4 (Fig. 1A), cultured embryonic lung cells, the lung
carcinoma cell line A549, the rhabdomyosarcoma cell
line RD, or glioma (not shown). The presence of the
hybrid transcripts in lymphocytes from seven blood do-
nors was determined by Southern blotting of the PCR
amplification products and hybridization to oligonucleo-
tide probes derived from sequences in the c7.9 clone:
HERV-H protease (C7PRR), HERV-E integrase (C7ENR),
and a sequence spanning the HERV-H/HERV-E splice
junction (SPLHYB) (Fig. 1B). A weak hybridization signal
was also detected from glioma (not shown). Additional
longer bands (600 and 670 bp) hybridized to probes
C7PRR and C7ENR while shorter bands present in some
of the blood donors (220 bp) hybridized only to C7ENR.
RT–PCR with PBHIS and the HERV-E integrase 39-primer
C7ENR, located 37 bp upstream of RHENR1, gave similar
results in hybridizations to C7PRR and SPLHYB but was
more sensitive than with PBHIS/RHENR1. Also embry-
onic lung cells and A549 were weakly positive with the
PBHIS/C7ENR primer pair (not shown).
To detect poly(A)1 HERV-H/HERV-E hybrid transcripts
in lymphocytes and other tissues, probe SPLHYB was
hybridized to a human multiple tissue northern blot and
washed at high stringency (Fig. 3). There was a quite
strong, smeary band in the lymphocyte lane, with a band
discernable at 2.5 kb. Other tissues showed bands at
other sizes, e.g., testis (1.4 kb). Probe C7ENR detected
only a weak smear in the lymphocyte lane, but two strong
bands (3.0- and 1.7-kb) in the testis lane (not shown).
Probe C7PRR and a HERV-H fragment of clone c7.9
detected only a diffuse smear in most lanes (not shown).
Primary structure of the spliced hybrid transcripts
A larger fragment (863 bp) of the HERV-H/HERV-E
hybrid transcript was amplified from blood donor lym-
phocyte RNA (PBMC5) using PBHIS and a second 39-
primer (41OMR1) derived from a position ca. 450 bp
farther downstream in the HERV-E env region (Fig. 4).
This fragment was cloned into a plasmid and four clones
were sequenced (three identical, e.g., c18.4 and one
differing by 0.3%) (Fig. 5A). The sequence of c18.4 up-
stream of the primer RHENR1 was identical to c7.9. The
HERV-H-derived nucleotide sequence of c18.4 was 92.5%
similar to the full-length HERV-H element RGH2 (Hirose
et al., 1993) in the leader and protease regions (ca. 320
bp). The nucleotide sequence of the HERV-E-derived part
of c18.4 (489 bp) was 93.5% similar to the corresponding
sequence in the HERV-E clone 4-1 (Repaske et al., 1985).
c18.4 contained two open reading frames (ORFs) initi-
ated by ‘strong‘ ATG codons (Kozak, 1989): ORF1, encod-
ing a putative 104 amino acid HERV-H protease/ HERV-E
integrase hybrid protein (Fig. 5B), and ORF2, encoding
the N-terminal part of the HERV-E envelope surface pro-
tein.
The PBHIS/41OMR1 863-bp fragment was only de-
tected in four of seven blood donors (Fig. 4). Using a
second 39-primer from a position 15 bp farther down-
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stream in the HERV-E env sequence, 41OMR2, all seven
blood donors were positive (not shown). PBHIS/41OMR2
products from one PBHIS/41OMR1-negative (PBMC2)
and one PBHIS/41OMR1-positive (PBMC4) blood donor
were cloned into a plasmid vector and a number of
clones (c20 and c21 clones, respectively) were se-
quenced. They consisted of two variants which differed
by only three nucleotides in a 45-bp stretch, one of which
corresponded to the second nucleotide of the 41OMR1
39-end target (Fig. 5A). PBMC2 contained only the
41OMR1-negative variant (9 clones) while PBMC4 con-
tained both the 41OMR1-positive (5 clones) (identical
with c18.6 in the corresponding region) and the 41OMR1-
negative (8 clones) variants. We tried to detect a possible
PCR polymorphism in genomic PBMC DNA from four
different blood donors with a 59-primer from c18.4 env
and 41OMR1 but obtained amplification products from all
four (not shown).
Alternative splicing patterns of HERV-H/HERV-E
hybrid transcripts
Two sequenced c20-clones with differing size (682
and 971 bp) turned out to be hybrid transcripts with the
structure HERV-H leader/HERV-E integrase (c20.21) and
HERV-H leader/HERV-E gag fragment/HERV-E integrase
FIG. 1. (A) RT–PCR using the primer pair PBHIS/RHENR1 on total RNA from two human T-cell leukemia cell lines (MOLT4 and H9) and PBMC
preparations from seven healthy blood donors. At the far left is molecular size marker VI (Boehringer-Mannheim). (B) Autoradiograms of Southern blots
of the amplification products hybridized to a HERV-H protease probe (C7PRR), a HERV-E integrase probe (C7ENR), a probe spanning the
HERV-H/HERV-E splice junction (SPLHYB), and a HERV-E gag probe (C20.8GAR). The positions of the hybrid amplification products are indicated by
arrowheads.
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(c20.8) (Fig. 2). The 289-bp HERV-E gag fragment was
90.3% similar to HERV-E clone 4-1 at nucleotide positions
1883–2173 (Repaske et al., 1985) and the fragment ends
corresponded to clone 4-1 sequences conforming to the
splice consensus sequences (Shapiro and Senepathy,
1987). These alternative splice products did not contain
other ORFs than the HERV-E env ORF. An oligonucleotide
probe from the gag exon (C20.8GAR) hybridized to bands
of various size in the PBHIS/RHENR1 and PBHIS/C7ENR
amplification products from all blood donors except one
(PBMC1) (Fig. 1B).
Adjacent HERV-H and HERV-E elements in the human
genome
To detect the genomic origin of the spliced hybrid
transcripts, we used the HERV-H 59-primer C7PRL1 (pro-
tease) and the HERV-E 39-primers C7ENR (integrase) and
C20.8GAR (gag) in PCR on human lymphocyte genomic
DNA. No amplification products were obtained with
C7PRL1/C7ENR but C7PRL1/C20.8GAR amplified a
2.8-kb fragment (not shown). This fragment was cloned
into a plasmid vector and one clone (g38.5) was se-
quenced. The HERV-H fragment between the 59-primer
and the splice donor (69 bp) was identical with the
sequence in the spliced hybrid transcripts, while the
HERV-E fragment between the SA and the 39-primer (264
bp) differed by one nucleotide from the gag sequence in
c20.8. The HERV-H sequence extended 1175 bp down-
stream from the C7PRL1 primer to a position between
the reverse transcriptase and RNAse H-encoding re-
gions of pol, abruptly followed by HERV-E leader and gag
sequences (1528 bp) starting with the glutamate tRNA
FIG. 2. (A) Regions joined in spliced transcripts are shown with the corresponding clones above the HERV-H and HERV-E genomes. PCR primers
used in cloning are shown by arrows and splice sites are indicated by flags. (B) The sequences of the splice junctions (SJs) indicated in (A) are shown
aligned with genomic HERV-H and HERV-E splice donor (SD) and splice acceptor (SA) sequences where the nucleotides removed by splicing are
shown in lower-case letters. The genomic sequences are from the RGH2 clone (Hirose et al., 1993) and the 4-1 clone (Repaske et al., 1985) except
for the ones indicated by an asterisk (*) which are from the PCR-generated clone g38.5. The probe SPLHYB is boxed in SJ2.
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PBS. The HERV-H element was 91.2% similar to an un-
published genomic element deposited in Genbank (Ac-
cession No. Z76735) with the same unusual pol structure
(deletion region A deleted, region B retained). The
HERV-E element was 92.7% similar to clone 4-1 (Repaske
et al., 1985).
The HERV-H/HERV-E structure is amplified and
dispersed to several chromosomes
A human/rodent somatic cell hybrid mapping panel
was screened for the presence of the HERV-H/HERV-E
structures by PCR using the primer pairs C7PRL1/
C20.8GAR and HPOL1/EGAR2 (from the internal se-
quence of g38.5). C7PRL1/C20.8GAR amplified 2.8-kb
fragments from chromosomes 4 and 7, while HPOL1/
EGAR2 amplified 1.3-kb fragments from chromosomes 3,
4, 7, 8, 11, and 12. All of these fragments hybridized to an
oligonucleotide probe spanning the HERV-H/HERV-E
genomic DNA junction (GENHYB) in Southern blots (Fig.
6) (bands from chromosomes 3 och 12 were visible at
longer exposure times). Preliminary direct sequencing of
PCR products from chromosomes 4, 7, 8, and 11 indi-
cated that distinct hybrid elements were indeed present
on different chromosomes and that the element on chro-
mosome 7 was probably the origin of clone 38.5. For a
more reliable analysis, amplification products from chro-
mosomes 4 (C7PRL1/C20.8GAR), 8, and 11 (HPOL1/
EGAR2) were cloned into a plasmid vector and se-
quenced (g39, g45, and g46 clones, respectively). Two
different elements were amplified from chromosome 11
(g46.1 and g46.2). Elements on different chromosomes
differed by 3.6–5.4% in the 1.3-kb region between the
HPOL1 and EGAR2 primers, while the two elements on
chromosome 11 differed by only 2.5%.
Presence of the HERV-H/HERV-E elements in other
primates
Genomic DNA from the hominoids Pan troglodytes
(chimpanzee), Gorilla gorilla (gorilla), Pongo pygmaeus
(orangutan), Hylobates lar (gibbon), and the old world
monkeys Macaca nigra (macaque) and Mandrillus
sphinx (mandrill) were analyzed for the presence of the
HERV-H/HERV-E elements by PCR using four different
primer pairs from the internal sequence of g38.5. All four
primer pairs amplified fragments of the expected size
from the chimpanzee and gorilla but not from the other
primate species (the HPOL1/EGAR2 amplificates are
shown in Fig. 7). Only the gorilla amplification products
hybridized to the probe GENHYB. The primer pair
C7PRL1/C20.8GAR amplified only from the gorilla and
this fragment did not hybridize to the GENHYB probe (not
shown). The gorilla 2.8-kb C7PRL1/C20.8GAR amplifica-
tion product was cloned into a plasmid vector and 1
clone (g40.6) was sequenced. The 1.3-kb HPOR1/EGAR2
amplification products from the chimpanzee (g42) and
gorilla (g41) were also cloned and sequenced (10 clones
from each species). Two different elements were found
in the chimpanzee (g42.2 and g42.6) which differed by
1.9% and three were found in the gorilla (g40.6, g41.2, and
g41.5), differing by 3.8–4.4%. The level of divergence
between elements in different species was 2.3–5.5%. The
two lowest divergence values belonged to two pairs of
human and gorilla elements which were 2.3 (g39.1/g40.6)
and 2.7% (g38.5/g41.6) different and shared common mu-
tations away from a consensus sequence.
All sequenced hybrid elements had the same HERV-H/
HERV-E junction, although some had point mutations
and small deletions that precluded the probe GENHYB
FIG. 3. Multiple tissue Northern blot II (Clontech) with 2 mg of mRNA
from spleen (lane 1), thymus (lane 2), prostate (lane 3), testis (lane 4),
ovary (lane 5), small intestine (lane 6), colon (lane 7), and PBMCs (lane
8) probed with SPLHYB and washed at 60°C.
FIG. 4. RT–PCR using the primer pair PBHIS/41OMR1 on total RNA
from two human T-cell leukemia cell lines (MOLT4 and H9) and PBMC
preparations from seven healthy blood donors. At the far left is molec-
ular size marker VI (Boehringer-Mannheim). (B) Autoradiogram of a
Southern blot of the amplification products hybridized to a probe span-
ning the HERV-H/HERV-E splice junction (SPLHYB). The position of the
hybrid amplification product is indicated by an arrowhead.
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from hybridizing to the chimpanzee elements and one
of the gorilla elements (Fig. 8A). The hybrid elements
must therefore have a common ancestor element. The
mean divergence from a consensus sequence would
be a rough estimate of the time of the amplification
event.This was found to be 2.2%, excluding positions
without a clear consensus and CpG dinucleotides.
Considering a neutral divergence rate of 0.12% per
million years (Gibbons, 1995), this divergence corre-
sponds to an amplification event 18 million years ago,
although more recent amplifications could have oc-
curred also (e.g., the two chimpanzee elements and
the two human elements on chromosome 11). A den-
drogram of the hybrid sequences based on similarities
in the HERV-H (691 bp) and HERV-E (605 bp) regions is
shown in Fig. 8B.
FIG. 5. (A) Nucleotide sequence of the multiply spliced HERV-H/HERV-E hybrid transcript, amplified by the primer pair PBHIS/41OMR2. The HERV-H
leader and protease and the HERV-E integrase/envelope regions, which are joined by splicing, are indicated. The amino acid translations of the ORFs
are shown under the nucleotide sequence. The positions of the PCR primers RHENR1 and 41OMR1 are indicated. The sequence upstream of RHENR1
is identical with clone c7.9 and the sequence upstream of 41OMR1 is identical with clone c18.4. The main sequence is the PBHIS/41OMR1 positive
variant (c20). The differing nucleotides in the PBHIS/41OMR1 negative variant (c21) are indicated in lowercase letters. (B) Alignment of ORF1
translated amino acid sequence with the corresponding putative HERV-H (clone RGH2, Hirose et al., 1993) protease (PR) and HERV-E (clone 4-1,
Repaske et al., 1985) integrase (IN) sequences. Frameshifts are indicated by a slash and stop codons by an asterisk (*).
224 LINDESKOG ET AL.
DISCUSSION
In this study, we show that spliced hybrid transcripts
between HERV-H and HERV-E elements are present in
normal human lymphocytes. We show that the genomic
DNA origin of the hybrid transcripts are adjacent HERV-H
and HERV-E elements and that they have been coampli-
fied and dispersed to several chromosomes.
The splicing of one HERV to another in hybrid tran-
scripts is a special case of HERV splicing to downstream
cellular sequences (Liu and Abraham et al., 1991;
Feuchter et al., 1992; Feuchter-Murthy et al., 1993). But it
is also a new type of interaction between retroviral ele-
ments. Previously identified interactions include genetic
recombination (Weiss et al., 1973; Itin and Keshet, 1983;
Stoye et al., 1991; Golovkina et al., 1994) at the RNA level
and complementation or phenotypic mixing (Vogt, 1967;
Ishimoto et al., 1977; Sherwin et al., 1978; Spector et al.,
1990) at the protein level. The consequences of spliced
transcript hybrids between different retroviral proviruses
could be altered tissue specificity of transcripts by the
promoter activity of another retroviral LTR and a produc-
tion of hybrid proteins. Indeed, the major HERV-H/
HERV-E hybrid transcript has a HERV-H protease/
HERV-E integrase hybrid ORF upstream of a HERV-E env
ORF. Similar protease/integrase hybrid ORFs are en-
coded by alternative splice products of normal HERV-H
env transcripts (Lindeskog and Blomberg, 1997) but there
is no evidence for the translation of these putative hybrid
proteins. The physical proximity of one HERV provirus to
another could be relatively rare but various types of
retroelements are often found close to each other (re-
viewed by Wilkinson et al., 1994). We have detected LTRs
from other HERV-H and HERV-E elements only ca. 200 bp
apart (unpublished data). Examples of integration of one
HERV into another are the HERV-K LTR in the S71 ele-
ment (Leib-Mo¨sch et al., 1993) and the HML-6 LTR in the
pol gene of another HML-6 element (Medstrand et al.,
1997).
The HERV-H hybrid element lacks the env and 39-LTR
SAs (Lindeskog and Blomberg, 1997) and the polyade-
FIG. 6. (A) PCR using the primer pair HPOL1/EGAR2 on DNA from somatic human/rodent cell lines corresponding to the human chromosomes, a
mouse (M) and a hamster (Ha) cell line and human PBMCs (Hu). (B) Autoradiogram of a Southern blot of the amplification products hybridized to a
probe spanning the HERV-H/HERV-E genomic junction (GENHYB). The position of the hybrid amplification product is indicated by an arrowhead. To
the left is the molecular weight marker, No. SM0211, (MBI Fermentas) indicated.
FIG. 7. (A) PCR using the primer pair HPOL1/EGAR2 on primate DNA. (B) Autoradiogram of a Southern blot of the amplification products hybridized
to the probe GENHYB. The position of the hybrid amplification products is indicated by an arrowhead. To the left is the molecular weight marker No.
SM0211 (MBI Fermentas) indicated.
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nylation signal, while the HERV-E element lacks the 59-
LTR. These facts probably make the situation ideal for
the production of spliced hybrid transcripts. The lack of
the env SA site could be a general feature of HERV-H
elements that splice to downstream cellular sequences.
The majority of HERV-H elements (800–900 copies) lack
this SA site which means that they could be especially
prone to affecting adjacent cellular genes. Thus, the
three examples mentioned above (plus this study) may
be only a fraction of this kind of HERV-H-promoted tran-
scription of cellular genes, which may be part of the
normal transcript flora in primates. HERV-H LTRs have
been shown to contain strong promoters (Feuchter and
Mager, 1990; Sjøttem et al., 1996), but since we have not
determined the 59-end of the hybrid transcripts, we can
not exclude the possibility that a promoter upstream of
the HERV-H element is used. The alternative inclusion of
the protease exon in the hybrid transcripts is like the
case in ordinary HERV-H transcripts (Lindeskog and
Blomberg, 1997) while the utilization of the alternative
HERV-E gag splice sites has not been observed before.
The HERV-H/HERV-E hybrid element is present in mul-
tiple copies with a divergence of 2.5–5.4% on at least six
different human chromosomes. The sequenced RT–PCR
amplification products (multiple clones from three differ-
ent individuals), however, indicate that only one element
is transcriptionally active in lymphocytes. This may be
due to different transcriptional contexts on the different
locations, e.g., methylation status. The 6 chromosomes
are among the 12 chromosomes that have been shown
FIG. 8. (A) Position of the PCR-generated genomic hybrid clones from human, gorilla, and chimpanzee DNA using the two primer pairs
HPOL1/EGAR2 and C7PRL1/C20.8GAR. The genomic HERV-H/HERV-E junctions in the clones are aligned with the corresponding regions in the
unpublished HERV-H Genbank entry Z76735 and the HERV-E clone 4-1 (Repaske et al., 1985). The clones are denoted HUM-A to E, CHI-A and B, and
GOR-A to C. The number in the human names denotes the chromosomal location. The probe GENHYB is boxed. (B) Unrooted tree from an alignment
of the clones in (A) based on divergencies from the HERV-H region downstream from the HPOL1 primer (691 bp) and from the HERV-E region upstream
from the EGAR2 primer (605 bp).
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to harbor full-length HERV-E elements (Taruscio and
Manuelidis, 1991). We found multiple copies of the hybrid
element also in the chimpanzee and gorilla but not in the
orangutan or old world monkeys. The amount of diver-
gence between elements within and among the three
hominoid species is in accordance with an event joining
the HERV-H and HERV-E elements followed by amplifi-
cation/dispersion after the orangutan/great African ape
split ca.17 million years ago (Sibley and Ahlquist, 1987). It
has been shown before that HERV-E elements have been
amplified and dispersed to different chromosomes to-
gether with flanking sequences (Steele et al., 1986).
These amplifications occurred after the old world mon-
key/hominoid split but before the chimpanzee/human
split and may have involved the same elements as the
ones reported here. Other amplifications of HERVs with
flanking sequences include the HERV-E/amylase struc-
ture (Samuelson et al., 1990) and the NP-2 elements on
the Y chromosome (Silver et al., 1987). Two of the three
gorilla elements are similar to and could be homologous
with two of the human elements, while the two chimpan-
zee elements are more divergent. The greater similarity
between the human and gorilla hybrid sequences com-
pared to the chimpanzee sequences is unexpected, but
could be explained by deletions of hybrid elements in the
chimpanzee genome. The two elements on the human
chromosome 11 have probably been duplicated within
that chromosome later than the original dispersion event.
The joining event was probably a deletion of intervening
sequences between a HERV-H and a HERV-E element
located relatively close to each other or an insertion of
one of the two HERVs into the other, also followed by a
deletion event. If the latter is the case, an amplification of
the hybrid elements by retroviral retrotransposition can-
not be excluded but the hybrid element would be at least
12 kb long.
There is a growing body of evidence of effects of
HERVs on adjacent cellular genes, which are regulated
by HERV promoters and enhancers. We here show that
HERVs may also control the expression of other HERVs.
This may be a rather rare event generally, but the ampli-
fied HERV-H/HERV-E structures constitute a significant
part of all env-containing HERV-E elements (15–20%).
Since these HERV-E elements lack the 59-LTR, they may
be dependent on the HERV-H promoter for transcription.
MATERIALS AND METHODS
Total RNA was prepared by using standard guani-
dinium thiocyanate lysis–CsCl centrifugation techniques
(Maniatis et al., 1982) from the following human cells and
tissues: lymphocytes (PBMCs) from healthy blood do-
nors isolated as described by Medstrand et al. (1992);
H9, a T-cell leukemia cell line, kindly provided by Dr. R. C.
Gallo (University of Maryland, Baltimore, MD); MOLT4,
another T-cell leukemia cell line (ATCC CRL 1582); cul-
tured embryonic lung cells; A549, a lung carcinoma cell
line (ATCC CCL 185); RD, a rhabdomyosarcoma cell line
(ATCC CCL 136); and glioma tissue (Lindeskog et al.,
1993). Total RNA was always treated with RNase-free
DNase (Promega). Genomic DNA was extracted from
one of the human PBMC preparations, P. troglodytes
pancreas, G. gorilla pancreas, P. pygmaeus skeletal
muscle, H. lar placenta, M. nigra placenta, and M. sphinx
liver by using standard methods (Ausubel et al., 1987).
The P. troglodytes and G. gorilla material was kindly
provided by Dr. Ulfur Arnason (Dept. of Genetics, Lund,
Sweden). DNA from the National Institute of General
Medical Sciences human/rodent somatic cell hybrid
mapping panel 2 (Dubois and Naylor, 1993) was kindly
provided by Dr. H. Yin (Dept. of Infectious Diseases and
Clinical Microbiology, Uppsala, Sweden).
Oligonucleotide primers and probes (Table 1) were
synthesized by Scandinavian Gene Synthesis or Pharma-
cia Biotech. The primers PBHIS and RHENR1 were de-
scribed before (Lindeskog and Blomberg, 1997). Reverse
transcription of RNA (1 mg) and PCR on cDNA and
genomic DNA (0.5 mg) was done as previously described
(Lindeskog et al., 1993), using a DNA thermal cycler
(Perkin–Elmer Cetus), 50 ng of each primer, and an
annealing temperature of 55°C. One-third of the reaction
volume was loaded on 1.8% agarose gels.
PCR products were cloned into a plasmid vector by
using the TA cloning kit (Invitrogen) or the pT7 Blue
T-vector kit (Novagen). Clones were sequenced in both
directions with M13 primers or internal primers either
by using the Sequenase kit, version 2.0 (USB), and
separating the sequencing reaction products on 6%
denaturing polyacrylamide gels, or by using the ABI
PRISM dye terminator cycle sequencing ready reac-
tion kit (Perkin–Elmer Cetus) and an ABI PRISM 310
genetic analyzer (Perkin–Elmer Cetus). Computer se-
quence analyses were done with the PCGENE pro-
grams (Intelligenetics). The trees were constructed by
using the NEIGHBOR and DRAWTREE programs from
the PHYLIP package, kindly provided by Dr. J. Felsen-
stein (Dept. of Genetics, Seattle, WA).
TABLE 1
Synthetic Oligonucleotides Used in the Experiments
Oligonucleotide Sequence
C7PRR GTGAGAGTTACGTAGAGCATCTGT
C7PRL1 GGCTTAGCAGCTGAAGACTGACAA
C7ENR ACTTTCCAGTCCTTGATCCACACT
SPLHYB ACACTCGATCATCCTCCACTGTGA
410MR1 CACACATCAGGTTGGTCCTTTCCTGG
410MR2 GCTCAGATGGGTTATAACACACAT
C20.8GAR AGGCCTCACAGTCTCTCCTAGA
HPOL1 AATATCCCATCCCACAGCATGCT
EGAR2 TCATAGTAACCCCATAGTCTCCA
GENHYB AGGTAACCAAGACTAGGGTGGG
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Southern blotting of PCR products was done on Hy-
bond N1 membranes (Amersham). Hybridization to
[g-32P]ATP-labeled oligonucleotide probes was done at
60 or 65°C as described previously (Ausubel et al., 1987)
using 0.5 pmol (1 mCi) of probe per ml. Washes were
done in 5 3 SSPE and 0.1% SDS at 65 or 70°C for 20 min.
Multiple tissue Northern blot II (Clontech) was hybrid-
ized as recommended by the manufacturer at 45°C using
0.5 pmol (1 mCi) of probe per ml. Washes were done in
5 3 SSPE, 0.1% SDS at 60°C for 15 min. The integrity of
the RNA was determined by hybridizing to an
[a-32P]dCTP-labeled b-actin cDNA control probe accom-
paning the blot as recommended by the manufacturer,
detecting discrete bands at 2 kb in all lanes.
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